TNF-inhibitors have several different safety issues than rituximab, tocilizumab and anakinra, and these distinctions may be important for certain RA patients. The risk/benefit ratio for the ...

A new study published recently in the journal Gut shows children with Crohn's who were prescribed anti-TNF (tumor necrosis factor) drugs following their diagnosis had an 82% lower risk of anal ...

An oral inhibitor would not only have delivery advantages over TNF-α inhibitors ... for much of the bone destruction in rheumatoid arthritis. “It seems like it affects all the partners that ...

Over 48 weeks, guselkumab proved effective for achieving low disease activity and/or remission across multiple psoriatic arthritis domains among patients with an inadequate response to prior tumor ...

A new study published recently in the journal Gut shows children with Crohn's who were prescribed anti-TNF (tumor necrosis factor) drugs following their diagnosis had an 82% lower risk of anal ...

A previously healthy man developed pulmonary symptoms 2 weeks after starting treatment with a tumour necrosis factor (TNF) inhibitor. A negative interferon-gamma release assay (IGRA) test was obtained ...

Differences in rates of bDMARD treatment initiation among US veterans with RA living in rural vs urban areas cannot be fully explained by location.

In Kids with Crohn's Disease, TNF Inhibitors Help Prevent Serious Complications, Data Suggests By Dennis Thompson HealthDay Reporter FRIDAY, Dec. 27, 2024 (HealthDay News) A specific class of anti ...